All Stories

  1. Functional performance in patients with COPD: association with treatment regimen, GOLD group, lung function, and symptom burden in a cross-sectional study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2018, Dove Medical Press

    Dr. shahid siddiqui, Dr. Bo Ding

  2. Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2018, Dove Medical Press

    Dr. shahid siddiqui

  3. A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2018, Dove Medical Press

    Dr. shahid siddiqui, Johan Clukers

  4. Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2018, Dove Medical Press

    Dr. shahid siddiqui

  5. Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2018, Dove Medical Press

    Dr. shahid siddiqui, Roberto RODRIGUEZ-ROISIN

  6. COPD exacerbation study design

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2016, Dove Medical Press

    Dr. shahid siddiqui